Cipla Limited (BOM:500087)

Market Cap	1.23T
Revenue (ttm)	271.45B
Net Income (ttm)	52.73B
Shares Out	n/a
EPS (ttm)	65.24
PE Ratio	23.28
Forward PE	24.40
Dividend	13.00 (0.88%)
Ex-Dividend Date	Aug 2, 2024

Volume	410,007
Average Volume	87,794
Open	1,519.00
Previous Close	1,512.00
Day's Range	1,497.60 - 1,539.00
52-Week Range	1,310.05 - 1,702.00
Beta	n/a
RSI	53.28
Earnings Date	May 13, 2025

About Cipla

Cipla Limited, together with its subsidiaries, engages in the manufacture, development, sale, and distribution of pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer’s disease, hypertension, arrhythmia, lipid abnormaliti...

• Industry: Pharmaceutical Preparations
• Founded: 1935
• Employees: 27,764
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 500087

Financial Performance

In 2024, Cipla's revenue was 271.45 billion, an increase of 6.30% compared to the previous year's 255.37 billion. Earnings were 52.73 billion, an increase of 27.93%.